Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Goodwill (2016 - 2021)

Historic Goodwill for Abeona Therapeutics (ABEO) over the last 7 years, with Q3 2021 value amounting to $32.5 million.

  • Abeona Therapeutics' Goodwill changed 0.0% to $32.5 million in Q3 2021 from the same period last year, while for Sep 2021 it was $32.5 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $32.5 million for FY2020, which is N/A changed from last year.
  • Abeona Therapeutics' Goodwill amounted to $32.5 million in Q3 2021, which was down 0.0% from $32.5 million recorded in Q2 2021.
  • In the past 5 years, Abeona Therapeutics' Goodwill ranged from a high of $32.5 million in Q4 2020 and a low of $32.5 million during Q1 2017
  • For the 5-year period, Abeona Therapeutics' Goodwill averaged around $32.5 million, with its median value being $32.5 million (2017).
  • Over the last 5 years, Abeona Therapeutics' Goodwill had its largest YoY gain of 0.0% in 2017, and its largest YoY loss of 0.0% in 2017.
  • Abeona Therapeutics' Goodwill (Quarter) stood at $32.5 million in 2017, then changed by 0.0% to $32.5 million in 2018, then changed by 0.0% to $32.5 million in 2019, then grew by 0.1% to $32.5 million in 2020, then dropped by 0.1% to $32.5 million in 2021.
  • Its Goodwill was $32.5 million in Q3 2021, compared to $32.5 million in Q2 2021 and $32.5 million in Q1 2021.